I am not a basher, I am not a short. I am definitely long for AMBS. I was just voicing a concern I have about the LymPro test and future data. If the data released was a sure thing the stock price would be a lot higher than it is right now. As an investor very knowledgeable about science, I am EXTREMELY excited about MANF and future applications and orphan designations, but not 100% sold on the LymPro test. That was the only point I was trying to get across, not bash the test or bash this company. For a young guy I think GC has done great things for this company and will continue to make the right decisions.